Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease
- 5 September 2013
- journal article
- review article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 29 (9) , 1493-1505
Abstract
Anemia management is an important component of the care provided to children with chronic kidney disease (CKD) and influences both morbidity and mortality risk. The introduction of recombinant human erythropoietin to the treatment regimen three decades ago revolutionized the therapy and significantly decreased the need for repeated blood transfusions and exposure to associated risks. Recent data on the efficacy and complications associated with erythropoietic-stimulating agent (ESA) usage has, however, prompted a reassessment of treatment-related recommendations. This review will address these recommendations, in addition to describing pediatric outcomes associated with current ESAs and presenting information on alternative ESAs, many of which will likely soon be incorporated into clinical practice.Keywords
This publication has 115 references indexed in Scilit:
- The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit TrialKidney International, 2012
- Dose-finding Study of Peginesatide for Anemia Correction in Chronic Kidney Disease PatientsClinical Journal of the American Society of Nephrology, 2011
- Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in miceJournal of Clinical Investigation, 2011
- Naturally Occurring Higher Hemoglobin Concentration Does Not Increase Mortality among Hemodialysis PatientsJournal of the American Society of Nephrology, 2011
- Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRDJournal of the American Society of Nephrology, 2010
- Hemoglobin Differences by Race in Children With CKDAmerican Journal of Kidney Diseases, 2010
- Masked Hypertension Associates with Left Ventricular Hypertrophy in Children with CKDJournal of the American Society of Nephrology, 2010
- Therapeutic strategies to slow chronic kidney disease progressionPediatric Nephrology, 2008
- Role of Gas6 in erythropoiesis and anemia in miceJournal of Clinical Investigation, 2008
- Anemia in children with chronic kidney diseasePediatric Nephrology, 2007